Looking for SS 31 peptide for sale? Learn what this research peptide does, typical dosing ranges, reported side effects, and how to vet vendors safely.
SS 31 peptide for sale listings appear on dozens of research chemical websites, but the compound — also known as elamipretide — is not FDA-approved for human use in the United States. Vendors sell it as a laboratory reference material, and any site presenting it as a treatment, supplement, or cure is making claims that regulators have not verified.
What Is the SS-31 Peptide?
SS-31 is a synthetic four-amino-acid peptide with the sequence D-Arg-Dmt-Lys-Phe-NH2. It is sold and studied under several names, including elamipretide, MTP-131, and Bendavia.
Unlike most peptides discussed in fitness circles, SS-31 is not a hormone, a growth factor, or a receptor agonist. Its proposed mechanism is structural: it binds to cardiolipin, a phospholipid on the inner mitochondrial membrane, and appears to stabilize that membrane and reduce reactive oxygen species in laboratory models.
That mitochondria-first mechanism is why researchers study it in conditions linked to cellular energy failure rather than in muscle-growth or fat-loss research. It behaves very differently from compounds that act on hormone signaling.
What Is SS-31 Peptide Used For?
If you are asking what is ss-31 peptide used for, the honest answer is that most human data comes from small clinical trials in rare mitochondrial diseases and age-related eye disease. None of those trials produced an approved product.
- Barth syndrome — a rare genetic disorder affecting cardiolipin and mitochondrial function; elamipretide was studied in the TAZPOWER program.
- Primary mitochondrial myopathy — a phase 3 trial evaluated daily subcutaneous dosing.
- Dry age-related macular degeneration — the ReCLAIM-2 phase 3 trial did not meet its primary endpoint.
- Heart failure and ischemia-reperfusion injury — mostly early-phase and animal work.
Results have been mixed across the board. Some Barth syndrome trials reported improvements in functional measures, while the larger ophthalmology program failed to hit its goal. SS-31 has never been confirmed in a large, well-controlled trial to treat any disease.
Outside of clinical research, SS-31 shows up in cell-culture and animal studies of kidney injury, neurodegeneration, and skeletal muscle aging. Those findings are preliminary and do not translate directly to human use.
How to Evaluate SS-31 Peptide for Sale Listings
Searching for ss 31 peptide for sale online returns a mix of legitimate laboratory suppliers and storefronts that provide little or no documentation. The difference between the two usually comes down to paperwork, not price.
Before ordering from any vendor, check the following:
- Certificate of analysis (COA) — it should list a batch number, purity by HPLC, and mass-spec confirmation.
- Third-party testing — a COA produced by the vendor itself is weaker than one from an independent lab.
- Labeling intent — research-only labeling matters legally, and it also signals the supplier is not making medical claims.
- Cold-chain handling — lyophilized peptides still need reasonable shipping and storage conditions.
- Payment and refund policy — vague contact details and crypto-only checkout are warning signs.
| Vendor type | Typical documentation | Independent COA | Relative risk |
|---|---|---|---|
| Established lab supplier | Batch COA with MS/HPLC data | Often | Lower |
| General research chem site | Basic COA, sometimes recycled | Sometimes | Moderate |
| Social media / gray market | None or screenshots | Rarely | High |
A low price per milligram is not evidence of value if the COA is missing. Independent testing of gray-market peptides has repeatedly found underdosed, mislabeled, or contaminated vials.
SS-31 Peptide Dosage: What the Research Shows
Dosing information circulating online is usually copied from trial protocols and then presented without context. The amounts below are investigational doses used in studies, not recommendations for self-administration.
| Research setting | Route studied | Dose range reported |
|---|---|---|
| Barth syndrome trials | Subcutaneous | 40 mg daily after a lower starting dose |
| Primary mitochondrial myopathy | Subcutaneous | 40 mg daily |
| Cardiac and acute-care studies | Intravenous infusion | 0.05–0.25 mg/kg per hour |
Vendor blogs — including pages that rank for ss-31 peptide dosage swolverine — often publish tidy dosage charts with no citation to a trial, a protocol, or an ethics approval. Treat those charts as marketing, not pharmacology.
SS-31 has never been evaluated for safety in healthy adults taking it for performance, recovery, or longevity. There is no established human dose for those purposes.
SS-31 Peptide Benefits and Side Effects Reported in Trials
Reported ss-31 peptide benefits and side effects come almost entirely from trial populations that were small, older, and clinically ill, which limits how much they tell you about anyone else.
In published trials, the most common complaints were:
- Injection site reactions such as pain, redness, or swelling
- Headache
- Nausea
- Dizziness or fatigue
Serious adverse events were uncommon, but the studies were short and underpowered to detect rare harms. Long-term safety data in humans is essentially absent, and no one knows how the peptide interacts with prescription medications.
Where SS-31 Fits Among Research Peptides
SS-31 belongs to a different category than growth-hormone secretagogues. Buyers browsing cjc 1295 peptide for sale listings are usually looking at pituitary signaling, while SS-31 research centers on mitochondrial membrane biology. The two are not substitutes for each other, and their safety profiles are not comparable.
That distinction matters when reading forum comparisons. Purported SS-31 benefits are described in terms of cellular energy metabolism, not muscle growth or fat loss.
Anyone considering this compound for personal use should talk with a healthcare professional first. Research peptides sold online are not inspected for sterility or accurate dosing the way prescription drugs are, and a product labeled "research use only" carries no guarantee of purity or safety.
Frequently Asked Questions
Is SS-31 peptide legal to buy in the United States?
SS-31 peptide is legal to purchase as a laboratory research chemical in most US states, but it is not FDA-approved for human consumption. Suppliers are expected to sell it strictly for research use. Buying or importing it for personal use sits in a legal gray area and can create customs issues.
What is SS-31 peptide used for in research?
Research has focused on mitochondrial dysfunction, including Barth syndrome, primary mitochondrial myopathy, and dry age-related macular degeneration. Results have been mixed, and the phase 3 dry AMD trial missed its primary endpoint. No regulatory agency has approved elamipretide for human use.
What side effects has SS-31 caused in trials?
The most frequently reported issues were injection site reactions, headache, nausea, and dizziness. Serious adverse events were uncommon in published trials, but those studies were short and enrolled small numbers of patients. Long-term safety in healthy adults is unknown.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.